| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/15/2002 | US20020111335 Bactericides, bacteriostats |
| 08/15/2002 | US20020111334 5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith |
| 08/15/2002 | US20020111319 2-halogenated derivatives of 5-0-desosaminyl-erythronolide A, their preparation process and their antibiotic use |
| 08/15/2002 | US20020111317 Sixteen-membered macrolide compounds |
| 08/15/2002 | US20020111313 Tripeptide dosage |
| 08/15/2002 | US20020111311 Antibiotics |
| 08/15/2002 | US20020111295 Agents for alleviating symptoms accompanied by inflammation |
| 08/15/2002 | US20020110868 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 08/15/2002 | US20020110858 Lymphocytic membrane proteins |
| 08/15/2002 | US20020110840 Detecting modulators of interferon generation; obtain cells, incubate with modulator, monitor concentration of inflammatory cytokine, amplified cytokine concentration indicates modulators |
| 08/15/2002 | US20020110836 PD-L2 molecules: novel PD-1 ligands and uses therefor |
| 08/15/2002 | US20020110575 Can be incorporated into a matrix, such as a paint or other coating composition, provide the matrix with resistance to fouling by organisms of more than one type; for use in shampoo, skin care products |
| 08/15/2002 | US20020110569 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 08/15/2002 | US20020110566 Administering fusion protein comprising a heat shock protein (hsp) or an immunostimulatory fragment thereof, and protein of a human papilloma virus (HPV), or an antigenic fragment thereof, for therapy of wart |
| 08/15/2002 | US20020110561 For use in therapy, sustained release of drugs |
| 08/15/2002 | US20020110557 Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use |
| 08/15/2002 | US20020110479 2-phenylphenol and natural and/or synthetic thymol dissolved in a isopropyl alcohol |
| 08/15/2002 | CA2447905A1 Hyperblebbing bacterial strains and use thereof for production of vaccines |
| 08/15/2002 | CA2437717A1 G-protein coupled receptors |
| 08/15/2002 | CA2437596A1 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 08/15/2002 | CA2437571A1 Receptors and membrane-associated proteins |
| 08/15/2002 | CA2437503A1 Hepatitis b virus treatment |
| 08/15/2002 | CA2437372A1 Oral itraconazole formulations and methods of making the same |
| 08/15/2002 | CA2437267A1 Mixture of peptides originating from a nef protein and applications thereof |
| 08/15/2002 | CA2437260A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 08/15/2002 | CA2436735A1 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof |
| 08/15/2002 | CA2436470A1 Intracellular signaling molecules |
| 08/15/2002 | CA2436435A1 Vaccine composition |
| 08/15/2002 | CA2436374A1 Water-soluble compositions of bioactive lipophilic compounds |
| 08/15/2002 | CA2436264A1 Endotoxin binding by lactic acid bacteria and bifidobacteria |
| 08/15/2002 | CA2434079A1 Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damaging cutaneous tissue |
| 08/15/2002 | CA2433439A1 Proteins and nucleic acids encoding same |
| 08/14/2002 | EP1231277A2 Biocompatible implant for in vivo formation of a neo-organ |
| 08/14/2002 | EP1231274A2 Modified porteinase inhibitors |
| 08/14/2002 | EP1231270A1 Novel protein and dna thereof |
| 08/14/2002 | EP1231212A1 Pharmaceutical compositions for the treatment of disorders of the CNS and other disorders |
| 08/14/2002 | EP1231211A1 Thiazolidinedione derivatives as antidiabetic agents |
| 08/14/2002 | EP1231210A2 Azole antifungal agents, processes for the preparation thereof, and intermediates |
| 08/14/2002 | EP1230927A1 Phyto-derivative disinfectant solution for veterinary use in the endo-mammary anti-mastitis treatment of milk-producing animals |
| 08/14/2002 | EP1230925A1 Anti-hiv compositions |
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230360A2 15 human secreted proteins |
| 08/14/2002 | EP1230357A2 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 08/14/2002 | EP1230268A2 Heteroclitic analogs of class i epitopes |
| 08/14/2002 | EP1230260A1 Hcv ns3 protease inhibitors |
| 08/14/2002 | EP1230257A2 Expression of immunogenic hepatitis b surface antigens in transgenic plants |
| 08/14/2002 | EP1230244A2 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 08/14/2002 | EP1230242A1 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 08/14/2002 | EP1230236A1 Compound with growth hormone releasing properties |
| 08/14/2002 | EP1230235A1 Compounds with antibacterial and antiparasitic properties |
| 08/14/2002 | EP1230224A1 Substituted 5-benzyl-2,4-diaminopyrimidines |
| 08/14/2002 | EP1230222A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 08/14/2002 | EP1230215A1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 08/14/2002 | EP1230214A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 08/14/2002 | EP1229934A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 08/14/2002 | EP1229933A2 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof |
| 08/14/2002 | EP1229932A2 Induction of mucosal immunity by vaccination via the skin route |
| 08/14/2002 | EP1229931A1 Fusion proteins of mycobacterium tuberculosis |
| 08/14/2002 | EP1229929A2 VACCINES FOR i MYCOPLASMA BOVIS /i AND METHODS OF USE |
| 08/14/2002 | EP1229925A2 Inhibitors of helicobacter pylori induced gastrointestinal diseases |
| 08/14/2002 | EP1229923A1 Inhibition of pathogens by bacillus coagulans strains |
| 08/14/2002 | EP1229913A1 Substituted 1-benzazepines and derivatives thereof |
| 08/14/2002 | EP1087987B1 A compound, wf002, production thereof and use thereof |
| 08/14/2002 | EP1077718B1 Enhancement of oxazolidinone antibacterial agents activity by arginine derivatives |
| 08/14/2002 | EP0959898A4 Lactoferrin variants and uses thereof |
| 08/14/2002 | EP0748335B1 Antibiotic stalobacins |
| 08/14/2002 | EP0722439B1 Hiv protease inhibitors |
| 08/14/2002 | EP0697876B1 Xenograft thymus |
| 08/14/2002 | EP0672193B1 Use of oligonucleotides having a conserved g 4 core sequence for the preparation of a medicament |
| 08/14/2002 | EP0554389B2 Molecular clones of hiv-1 and uses thereof |
| 08/14/2002 | EP0535034B1 Pharmaceutically active benzoquinazoline compounds |
| 08/14/2002 | DE10158523A1 Hemmung der Transkription eines Zielgens in einer Zelle oder in Geweben Inhibition of transcription of a target gene in a cell or in tissue |
| 08/14/2002 | DE10104055A1 Verwendung von Kohlenhydraten zur Beseitigung von Darminfektionen bei Tieren Use of carbohydrates on the Elimination of intestinal infections in animals |
| 08/14/2002 | CN1364195A Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 08/14/2002 | CN1364193A BHV-1 gene-deleted virus vaccine |
| 08/14/2002 | CN1364171A Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs |
| 08/14/2002 | CN1364158A Mutilin derivatives and their use as antibacterials |
| 08/14/2002 | CN1364122A Drive system |
| 08/14/2002 | CN1364093A Improvement of T cell mediated immunity |
| 08/14/2002 | CN1364085A Use of phyllanthus for treating chronically inflammatory and fibrotic processes |
| 08/14/2002 | CN1364077A Multilayer pharmaceutical product for release in the colon |
| 08/14/2002 | CN1364076A Oral form of administration containing probiotic micro-organisms |
| 08/14/2002 | CN1364056A Pyrithione biocides enhanced by silver, copper, or zinc ions |
| 08/14/2002 | CN1363681A Activated lymphocyte from umbilical cord blood, preparations containing it as main content and method therefor |
| 08/14/2002 | CN1363558A Antibacterial frog skin peptide derivative |
| 08/14/2002 | CN1363392A Process for preparing instant particles for treating hepatitis B |
| 08/14/2002 | CN1363377A Medicine for treating cold |
| 08/14/2002 | CN1363374A Medicine for treating epidemic hemorrhagic fever |
| 08/14/2002 | CN1363371A Multifunctional bio-active medicine for preventing and curing AIDS |
| 08/14/2002 | CN1363369A Oral liquid 'Mieailing' and its preparing process |
| 08/14/2002 | CN1363366A Antivirus defervescent |
| 08/14/2002 | CN1363365A Extraction of herbs by heating alcohol |
| 08/14/2002 | CN1363334A Nano medicine 'Dabuyin' and its preparing process |
| 08/14/2002 | CN1363332A Nano medicine 'Zixue' and its preparing process |
| 08/14/2002 | CN1363322A Nano medicine 'Yinhuang' and its preparing process |
| 08/14/2002 | CN1363302A Nano medicine 'Fangfeng Tongsheng' and its preparing process |
| 08/14/2002 | CN1363283A Beetoxin injection and its preparing process |
| 08/14/2002 | CN1363278A Itch-tinea mixture |
| 08/14/2002 | CN1089004C Dressing for treating infantile bronchitis and pulmonitis and its preparation |
| 08/14/2002 | CN1089000C Power-medicine for chicken |